Neonc Technologies Holdings, Inc. (NTHI): EPS (Diluted)
-$3.20
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.20 | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$0.69 | n/a | 2026-03-31, From 2024-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$3.20 | n/m |
| Altimmune, Inc. (ALT) | 2025-12-31 | -$1.00 | n/m |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | -$16.06 | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$0.38 | n/m |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | -$10.63 | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$5.84 | n/m |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | -$1.00 | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$1.81 | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$0.50 | n/m |
Compare NTHI, ALT, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗